Thomas Schinecker is an Austrian-German pharmaceutical executive who has served as the Chief Executive Officer of the Roche Group since March 2023. In this role, he succeeded Severin Schwan. He is also slated to become President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in 2025, having served as Vice-President since 2022, and chairs the Biopharmaceutical CEOs Roundtable (BCR).